Virogin Biotech
Dr. George R. Blumenschein, Jr. is a Professor of Medicine in the Department of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He has authored or co-authored numerous papers and book chapters regarding the management of lung and head and neck cancers. He is leading the adoptive T-cell program with the goal of developing this class of therapeutics for treating lung and head & neck cancers, and serves as the Principal Investigator for multiple clinical trials.
This person is not in the org chart
This person is not in any offices
Virogin Biotech
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need.